Condition: Fertility Disorders · Hypothalamic Dysfunction · Sponsor: Imperial College London
We want to find out what happens to reproductive hormone levels; Luteinising Hormone (LH), Follicle Stimulating Hormone (FSH), testosterone and oestradiol when kisspeptin is administered to people for a period of 8 days each month, using either placebo (saline) or kisspeptin in doses of 0.1, 0.3 or 1.0 nmol/kg/hour.
This description comes directly from the study's public registry record.
ALi Abbara, PhD MRCP · 020 8383 3242 · ali.abbara@imperial.ac.uk
Debbie A Papadopoulou, BSc MRes · 020 8383 3242 · d.papadopoulou@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| Imperial College NHS Healthcare Trust | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02081924